WallStreetZenWallStreetZen

NASDAQ: XGN
Exagen Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Exagen earnings were -$15.1M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. The latest XGN earnings report on Dec 31, 2024 announced Q4 2024 earnings of -$3.8M, down 25.2% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, XGN reported annual earnings of -$15.1M, with -36.2% growth. The next XGN earnings date is May 12, 2025.

XGN earnings history

Current Revenue
$55.6M
Current Earnings
-$15.1M
Current Profit Margin
-27.2%

XGN Return on Equity

Current Company
-100.8%
Current Industry
-10.9%
Current Market
34.1%
XGN's Return on Equity (-100.8%)... subscribe to Premium to read more.
High Return on Equity Performance

XGN undefined

Current Company
-32.1%
Current Industry
5.7%
XGN is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when XGN announces earnings.

XGN undefined

Current Company
-41.27%
Current Industry
9.7%
XGN's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

XGN vs Diagnostic & Research Stocks

TickerEBITDAEarningsY/Y EarningsEPS
XGN-$10.26M-$15.12MN/A-$0.83
FONR$18.62M$7.31M-11.70%$1.17
OCX-$59.28M-$60.93MN/A-$4.66
BDSX-$28.90M-$42.93MN/A-$0.33
NOTV-$34.84M-$120.69MN/A-$4.61
View Top Diagnostic & Research Stocks

XGN earnings dates

Next earnings date
May 12, 2025

Exagen Earnings Reports & History FAQ

What were Exagen's earnings last quarter?

On XGN's earnings call on Invalid Date, Exagen (NASDAQ: XGN) reported Q4 2024 earnings per share (EPS) of -$0.20, up 35.48% year over year. Total XGN earnings for the quarter were -$3.76 million. In the same quarter last year, Exagen's earnings per share (EPS) was -$0.31.

If you're new to stock investing, here's how to buy Exagen stock.

When does Exagen report earnings?

The next XGN earnings date is Invalid Date. Add XGN to your watchlist to be reminded of Exagen's next earnings date.

Is Exagen profitable or losing money?

As of the last Exagen earnings report, Exagen is currently losing money. Exagen's net profit (also called net income) for the twelve months ending Dec 31, 2024 was -$15.12 million, a 36.19% decrease year over year.

What was XGN's earnings growth in the past year?

As of Exagen's earnings date in Invalid Date, Exagen's earnings has grown year over year. XGN earnings in the past year totalled -$15.12 million.

What are Exagen's earnings expectations?

The current EPS estimate for Exagen's earnings report in Invalid Date is -$0.36.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.